Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
5.16
-0.07 (-1.34%)
At close: Oct 23, 2025, 4:00 PM EDT
5.16
0.00 (0.00%)
After-hours: Oct 23, 2025, 7:02 PM EDT
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $48.39 million as of October 23, 2025. Its market cap has increased by 231.42% in one year.
Market Cap
48.39M
Enterprise Value
8.30M
1-Year Change
231.42%
Ranking
Category
Stock Price
$5.16
Market Cap Chart
Since January 31, 2014, Tvardi Therapeutics's market cap has decreased from $282.00M to $48.39M, a decrease of -82.84%. That is a compound annual growth rate of -13.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2025 | 49.00M | 75.00% |
| Dec 31, 2024 | 28.00M | -30.86% |
| Dec 29, 2023 | 40.50M | -92.98% |
| Dec 30, 2022 | 577.10M | -11.37% |
| Dec 31, 2021 | 651.10M | -13.65% |
| Dec 31, 2020 | 754.00M | 0.27% |
| Dec 31, 2019 | 752.00M | 46.65% |
| Dec 31, 2018 | 512.80M | 28.49% |
| Dec 29, 2017 | 399.10M | 57.44% |
| Dec 30, 2016 | 253.50M | -44.78% |
| Dec 31, 2015 | 459.10M | 102.16% |
| Dec 31, 2014 | 227.10M | -19.47% |
| Jan 31, 2014 | 282.00M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.08B |
| Johnson & Johnson | 462.74B |
| AbbVie | 403.22B |
| UnitedHealth Group | 326.45B |
| AstraZeneca | 258.15B |
| Novartis AG | 254.23B |
| Novo Nordisk | 237.27B |
| Abbott Laboratories | 219.89B |